Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cisco Systems, Inc. (CSCO): This Tech Powerhouse Has 20% Upside Potential

Page 1 of 2

Against all odds, Cisco Systems, Inc. (NASDAQ:CSCO) has managed to beat estimates yet again. The company reported another stellar quarter, showing further improvements in its enterprise business. The quarter also makes the case for a long-term investment in the company due to a smooth execution of Cisco’s new strategic plan and stable performance despite a poor industry outlook. Analysis shows that the company has 20% upside at current levels and is a strong buy.

Fundamental review

Cisco Systems, Inc. (NASDAQ:CSCO)

Technology giant Cisco Systems, Inc. (NASDAQ:CSCO) recently reported its first-quarter earnings. The market was expecting Cisco to post revenue of $12.2 billion and an EPS of $0.49. These assumptions were led by a weak global economy and the attempt of Cisco Systems, Inc. (NASDAQ:CSCO) to shift its business to more profitable ventures.

However, the company surprised the entire market by posting 14% year-over-year growth in EPS, which was reported at $0.51. Revenue also saw a healthy climb of 5% to $12.2 billion as compared to approximately $11.6 billion last year.

Cisco Systems, Inc. (NASDAQ:CSCO) continued its strong performance with an exceptionally strong performance in NGN routing, which was slightly offset by weak services and switching segments. NGN routing saw impressive 10% quarter-over-quarter growth, while switching shrunk by 3.4%, and the services segment was flat.

The growth in NGN is another indication that enterprise demand has been strong despite fears that the company will face growth shortfalls due to a weak global economy. The bottom line was also positively affected by a product mix more tiled toward services, which resulted in a better-than-expected gross margin of 63%.


If we compare the quarterly performance of Cisco Systems, Inc. (NASDAQ:CSCO) with peers, the networking giant seems to be in a much better position to face the international economic slowdown.

Juniper Networks, Inc. (NYSE:JNPR) has also recently reported its quarterly earnings and disappointed the market by missing its earnings forecast. The company was hit pretty hard by the heavy spending cuts of the U.S. government, which is one of the company’s main clients. It expects the weak performance to continue and projects second-quarter revenue of around $1.1 billion and EPS in the range of $0.22 to $0.26; below analyst expectations of $0.27.

International Business Machines Corp. (NYSE:IBM) also saw its biggest single-day decline in the last eight years after reporting its first-quarter report. The company missed both EPS and revenue expectations by reporting EPS of $3.00 on revenue of $23.4 billion. The miss can be attributed to a general revenue decline across all key segments due to company’s inability to sign on more customers and a large hardware decline. Hardware sales declined 17% due to weak mainframe, x-86 and storage sales.


The recent developments in the technology sector are pointing toward the importance of services-based business models. The slowdown in hardware sales has led to poor performance of Juniper Networks, Inc. (NYSE:JNPR) and International Business Machines Corp. (NYSE:IBM). Cisco has been shielded by its growth in NGN routing and services and a heavy revenue mix.

Investors should focus on companies which rely mostly on services revenue or with long-term plans to focus on this segment. The strong management of IBM makes it a buy despite recent revenue shortfalls but investors are better off avoiding Juniper. There seems to be no immediate end to budget and spending cuts by the U.S. government, which is not a good sign for Juniper.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!